Alvotech (ALVO) Exchange Rate Effect (2021 - 2026)
Alvotech's (ALVO) quarterly Exchange Rate Effect came in at -$2.1 million in Q2 2026, up 52.67% on a YoY basis from -$1.4 million in Q2 2025, and down 264.71% quarter-over-quarter from $1.3 million in Q1 2026.
Analysis
Alvotech (ALVO) Exchange Rate Effect (2021 - 2026) Analysis & Trends
Alvotech (ALVO) has reported Exchange Rate Effect for 6 consecutive years, with -$2.1 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Exchange Rate Effect rose 52.67% year-over-year to -$2.1 million; the trailing twelve-month figure through Jun 2026 stood at $250000.0 (down 89.96% YoY), and the FY2025 full-year result was $4.5 million, up 440.71% from the prior year.
- Exchange Rate Effect eased to -$2.1 million in Q2 2026 per ALVO's latest filing, from $1.3 million in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $279.0 million in Q2 2023 and bottomed at -$218.7 million in Q1 2024.
- Historically, Exchange Rate Effect has averaged $19.9 million across 5 years, with a median of -$153500.0 in 2022.
- The sharpest annual moves came in 2023 and 2025: Exchange Rate Effect jumped 13064.27% in 2023, then tumbled 1162.46% in 2025.
- Over 5 years, Exchange Rate Effect stood at -$113000.0 in 2022, then sank by 71.68% to -$194000.0 in 2023, then slumped by 582.47% to -$1.3 million in 2024, then sank by 1162.46% to -$16.7 million in 2025, then jumped by 87.24% to -$2.1 million in 2026.
- According to Business Quant data, Exchange Rate Effect over the past three periods registered -$2.1 million, $1.3 million, and -$16.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn | -5.00 Mn |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | -3.30 Mn |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn | 411,947.57 |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn | -164,000.00 |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn | -2.00 Mn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | -2.13 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 67,000.00 |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn | 16,000.00 |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn | - |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2.13 Mn |
| Mar 31, 2026 | 1.30 Mn |
| Dec 31, 2025 | -16.72 Mn |
| Sep 30, 2025 | 17.80 Mn |
| Jun 30, 2025 | -4.51 Mn |
| Mar 31, 2025 | 7.93 Mn |
| Dec 31, 2024 | -1.32 Mn |
| Sep 30, 2024 | 390,000.00 |
| Jun 30, 2024 | 217.90 Mn |
| Mar 31, 2024 | -218.73 Mn |
| Dec 31, 2023 | -194,000.00 |
| Jun 30, 2023 | 278.99 Mn |
| Dec 31, 2022 | -113,000.00 |
| Jun 30, 2022 | -2.15 Mn |
| Dec 31, 2021 | 3.07 Mn |
| Sep 30, 2021 | -6.85 Mn |